Background and Objective: Most patients with prolactinomas receive pharmacological
treatment only, resulting in limited research on the predictors of successful prolactinoma …

Objective Prolactin-secreting tumors respond well to medical management, with a few
patients requiring surgery. We conducted a systematic review and meta-analysis to study the …

Context Surgical management of prolactinomas is an important treatment for patients
intolerant of dopamine agonist therapy. However, predictors of postoperative outcomes …

Context Little systematic data on male prolactinomas treated with surgery are available.
Objective To clarify the clinical features and confirm the efficacy of transsphenoidal surgery …

Context Few studies have recently re-examined the efficacy of neurosurgery in prolactinoma
patients operated for various indications. Objective To analyze outcomes of patients with a …

Abstract Purpose Dopamine agonists (DAs) have long been the recommended first-line
treatment for prolactinoma. Given the remarkable developments in surgical techniques …

Simple Summary Prolactinomas constitute a subgroup of pituitary adenomas for which there
are several treatment options. Dopamine agonists (DA), since their introduction, have shown …

Context: Prolactinoma is the most common subtype of functional pituitary adenoma. Effective
therapy is required for women of child-bearing age to achieve remission at serum prolactin …

BACKGROUND/AIMS: Prolactinomas are the most common tumors of the pituitary gland.
Only few studies have documented gender-related differences in the growth and …

Purpose Renewed interest in transsphenoidal surgery (TSS) as a therapeutic option for
prolactinomas has emerged. Methods Based on contemporary literature and own …